Register
SIFI offers a complete range of products for the treatment of the most common eye conditions, including pharmaceuticals, nutraceuticals, medical and surgical devices and eye care products.
If you are an Ophthalmologist or Pharmacy Specialist please login or register below to access product pages.
 
Username* (minimo 6 caratteri)
 
Email*
 
Password*
 
Confirm password*
 
Nome*
 
Cognome*
 
Indirizzo
 
Citta
 
Provincia
 
Cap
 
Telefono
 
Cellulare
 
Fax
 
Data di nascita
 
Luogo di nascita
 
Provincia di nascita
 
Sesso
 
Codice fiscale
 
Attività professionale
 
Iscrizione albo di*
 
Col numero*
 
Azienda
 
Settore azienda
 
Funzione azienda
 
Informativa ai sensi del Regolamento europeo (UE) 2016/679

Dichiaro di aver letto l'informativa sulla privacy e sulla base di quanto in essa riportato:
Acconsento al trattamento dei dati personali per le finalità indicate nell'informativa
Il mancato flag nell’apposita casella non permetterà all’utente di andare avanti nella registrazione.
 
Accetto l'informativa ai sensi del Regolamento europeo (UE) 2016/679
 
Confirmation Code* :
 

 
 
 
 
General questions info@sifigroup.com   Products Quality QualityUnit@sifigroup.com       Pharmacovigilance pharmacovigilance@sifigroup.com   Vigilance...
 
Quality We CARE for patients; all patients, even those frequently left behind by the industry, such as individuals afflicted by rare diseases.   SIFI’s 80-year long history is distinguished...
 
International Markets In the last years SIFI has undergone a virtuous growth of its business, evolving into an industrial group of companies, consolidating domestic leadership and expanding...

On our Social Channels

From our News Center

This partnership allows both companies to strengthen their ophthalmic product portfolio in Europe. Madrid, Oct. 15, 2018 – SIFI, Italian leader in the development and marketing of ophthalmic...
 

 

05 October

SIFI is pleased to announce the opening of SIFI IBERICA SL, a new wholly owned Spanish subsidiary, located in Madrid. The latest SIFI branch has been created with the aim...
Follow Us!